Article information
Full text is only aviable in PDF
References
[1.]
A.E. Grulich, M.T. Leeuwen, M.O. Folster, C.M. Vajdic.
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.
Lancet, 370 (2007), pp. 59-67
[2.]
I. Penn.
Cancers complicating organ transplantation.
N Engl J Med, 323 (1990), pp. 1767
[3.]
J.D. Christie, L.B. Edwards, P. Aurora, F. Dobbels, R. Kirk, A.O. Rahmel, et al.
Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart-lung transplantation report-2008.
J Heart Lung Transplant, 27 (2008), pp. 957-969
[4.]
I. Penn.
Incidence and treatment of neoplasia after transplantation.
J Heart Lung Transplant, 12 (1993), pp. S328-S336
[5.]
M.G. Crespo-Leiro, L. Alonso-Pulpón, J.A. Vázquez de Prada, L. Almenar, J.M. Arizón, V. Brossa, et al.
Malignancy after heart transplantation: incidence, prognosis and risk factors.
Am J Transplant, 8 (2008), pp. 1031-1039
[6.]
I. Penn.
Cancers in cyclosporine-treated vs azathioprine-treated patients.
Transplantat Proc, 28 (1996), pp. 876-878
[7.]
I. Penn.
Post-transplant malignancy: the role of immunosuppresion.
Drug Saf, 23 (2000), pp. 101-113
[9.]
H. Valantine.
Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of the novo malignancies after heart transplantation. Lessons learned from renal transplantation and oncology.
J Heart Lung Transplant, 26 (2007), pp. 557-564
[10.]
R.C. Walker, C.V. Paya, W.F. Marshall, J.G. Strickler, R.H. Wiesner, J.A. Velosa, et al.
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for post-transplantation lymphoproliferative disorder in adult heart, lung and other solid organ transplantations.
J Heart Lung Transplant, 14 (1995), pp. 214-221
[11.]
S. Roithmaier, A.M. Haydon, S. Loi, D. Esmore, A. Griffiths, P. Bergin, et al.
Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience.
J Heart Lung Transplant, 26 (2007), pp. 845-849
[12.]
H. Myron Kauffman, M.A. McBride, W.S. Cherikh, P.C. Spain, W.H. Marks, A.M. Roza.
Transplant tumor registry: donor related malignancies.
Transplantation, 74 (2002), pp. 358
[13.]
S.A. Birkeland, H.H. Storm.
Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors.
Transplantation, 74 (2002), pp. 1409
[14.]
A.G. de Soyza, J.H. Dark, D.V. Parums, A. Curtis, P.A. Corris.
Donor-acquired small cell lung cancer following pulmonary transplantation.
Chest, 120 (2001), pp. 1030-1031
[15.]
N.A. Abrahams, M. Meziane, P. Ramalingam, A. Mehta, M. Decamp, C.F. Farver.
Incidence of primary neoplasms in explanted lungs: long-term follow-up from 214 lung transplant patients.
Transplant Proc, 36 (2004), pp. 2808-2811
[16.]
J.C. Peñalver Cuesta, C. Jordá Aragón, J. Escrivá Peiró, J. Cerón Navarro, V. Calvo Medina, J. Padilla Alarcón.
Lung transplantation: bronchogenic carcinoma in the native lung.
Arch Bronconeumol, 43 (2007), pp. 126-128
[17.]
P. Morales, J. Torres, A. Pérez-Enguix, A. Solé, A. Pastor, A. Segura, et al.
Lymphoproliferative disease after lung and heart-lung transplantation: first description in Spain.
Transplant Proc, 37 (2005), pp. 4059-4063
[18.]
S.M. Levine, L. Angel, A. Anzueto, J. Susanto, J.I. Peters, E.Y. Sako, et al.
A low incidence of post-transplant lymphoproliferative disorder in 109 lung transplant recipients.
Chest, 116 (1999), pp. 1273-1277
[19.]
D.J. Weissmann, J.A. Ferry, N.L. Harris, D.N. Louis, F. Delmonico, I. Spiro.
Post-transplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.
Am J Clin Pathol, 103 (1995), pp. 748-755
[20.]
M.N. Hanson, V.A. Morrison, B.A. Peterson, K.T. Stieglbeuer, V.L. Kubic, S.R. McCormick, et al.
Post-transplant T-cell lymphoproliferative disorders–an aggressive, late complication of solid-organ transplantation.
Blood, 88 (1996), pp. 3626-3633
[21.]
S. Euvrard, J. Kanitakis, A. Claudy.
Skin cancers after organ transplantation.
N Engl J Med, 348 (2003), pp. 1681-1691
[22.]
Y.H. Choi, A.N. Leung, S. Miro, C. Poirier, S. Hunt, J. Theodore.
Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings.
J Thorac Imaging, 15 (2000), pp. 36-40
[23.]
S.M. Arcasoy, C. Hersh, J.D. Christie, D. Zisman, A. Pochettino, B.R. Rosengard, et al.
Bronchogenic carcinoma complicating lung transplantation.
J Heart Lung Transplant, 20 (2001), pp. 1044-1053
[24.]
R.P. Dickson, R.D. Davis, J.B. Rea, S.M. Palmer.
High frequency of bronchogenic carcinoma after single-lung transplantation.
J Heart Lung Transplant, 25 (2006), pp. 1297-1301
Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica
